Showing results (311-320 of 513) with videos related to
Sort By:
Pageof 52
Lung Cancer (Amsterdam, Netherlands)|December 27, 2008
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinomaSung Hoon Sim, Sae-Won Han, Do-Youn Oh, et al.Lung Cancer (Amsterdam, Netherlands)|December 9, 2008
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKIHyeon Gyu Yi, Hye Jin Kim, Yu Jung Kim, et al.Lung Cancer (Amsterdam, Netherlands)|January 17, 2009
Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancerHee Jun Kim, Yu Jung Kim, Myung-Deok Seo, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgeryWon Kyung Cho, Dongryul Oh, Hong Kwan Kim, et al.Scientific Reports|December 18, 2023
Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancerKyeonghui Kim, Hyemin Kim, Inkyung Shin, et al.Lung Cancer (Amsterdam, Netherlands)|September 8, 2006
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patientsSae-Won Han, Tae-You Kim, Kyung-Hun Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorYoujin Kim, Chu Hyun Kim, Ho Yun Lee, et al.Japanese Journal of Clinical Oncology|July 3, 2004
Extrapulmonary small-cell carcinoma: a single-institution experienceJung Han Kim, Se-Hoon Lee, Jinny Park, et al.Cancer Research and Treatment|July 21, 2014
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid CancerHyun Jung Lee, Dae-Seog Heo, Joo-Youn Cho, et al.Science Advances|December 3, 2025
B cell-reactive neoantigens boost antitumor immunityJeong Yeon Kim, Jinhyeon An, Soyeon Kim, et al.Pageof 52